|
|
||||||||
Journal of Lipid Research, Vol 32, 941-951, Copyright © 1991 by Lipid Research, Inc.
ARTICLES |
M Seishima, CL Bisgaier, SL Davies and RM Glickman
Department of Medicine, Columbia University College of Physicians and Surgeons, New York 10032.
Regulatory mechanisms of hepatic apolipoprotein synthesis were studied in groups of male Sprague-Dawley rats made severely hypolipidemic by treatment with pharmacological doses of 17 alpha-ethinyl estradiol. Treatment resulted in a marked reduction of plasma cholesterol and apolipoproteins B, A-I, and A-IV. Hepatic apoA-I mRNA and apoA-I synthesis were increased in the ethinyl estradiol-treated animals. Hepatic apoA-IV protein synthesis rates were unaltered; however, a reduction of the apoA-IV mRNA level was observed. Diet-control studies suggested the effects of 17 alpha-ethinyl estradiol on apoA-I, unlike those on apoA-IV, appeared to be related to the steroid and not to reduced caloric intake. Livers of control and ethinyl estradiol-treated rats synthesized both apoBH and apoBL. Total hepatic apoB (apoBL plus apoBH) synthesis and apoB mRNA levels in the ethinyl estradiol-treated rats were similar to ad libitum fed or diet-controls. In ad libitum fed and diet-control rats, 21% and 32%, respectively, of newly synthesized hepatic apoB was apoBH. In contrast, 47% of the newly synthesized apoB in the ethinyl estradiol-treated animal was apoBH. Nucleotide sequence analysis of hepatic apoB mRNA confirmed a marked decrease in the proportion of the apoBL mRNA in ethinyl estradiol-treated animals. After cessation of 17 alpha-ethinyl estradiol treatment, the hepatic apolipoprotein A-I synthesis rate, apolipoprotein A-I and A-IV mRNA levels, and the apoBH and apoBL synthesis rates, as well as plasma apolipoprotein and cholesterol levels, returned to normal. A major finding of the present study is that pharmacological doses of ethinyl estradiol do not affect total hepatic apoB synthesis, but increase the relative amount of apoBH synthesized.
This article has been cited by other articles:
![]() |
A. P. Patterson, Z. Chen, D. C. Rubin, V. Moucadel, J. L. Iovanna, H. B. Brewer Jr., and T. L. Eggerman Developmental Regulation of Apolipoprotein B mRNA Editing Is an Autonomous Function of Small Intestine Involving Homeobox Gene Cdx1 J. Biol. Chem., February 21, 2003; 278(9): 7600 - 7606. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zhang, J.-J. Jiao, B. R. Bhavnani, and S.-P. Tam Regulation of human apolipoprotein A-I gene expression by equine estrogens J. Lipid Res., November 1, 2001; 42(11): 1789 - 1800. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Couse and K. S. Korach Estrogen Receptor Null Mice: What Have We Learned and Where Will They Lead Us? Endocr. Rev., June 1, 1999; 20(3): 358 - 417. [Abstract] [Full Text] |
||||
![]() |
R. A. K. Srivastava, N. Srivastava, M. Averna, R. C. Lin, K. S. Korach, D. B. Lubahn, and G. Schonfeld Estrogen Up-regulates Apolipoprotein E (ApoE) Gene Expression by Increasing ApoE mRNA in the Translating Pool via the Estrogen Receptor alpha -Mediated Pathway J. Biol. Chem., December 26, 1997; 272(52): 33360 - 33366. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Harnish, S. Malik, E. Kilbourne, R. Costa, and S. K. Karathanasis Control of Apolipoprotein AI Gene Expression through Synergistic Interactions between Hepatocyte Nuclear Factors 3and 4 J. Biol. Chem., June 7, 1996; 271(23): 13621 - 13628. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Zuckerman and N. Bryan-Poole Estrogen-Induced Alterations in Lipoprotein Metabolism in Autoimmune MRL/lpr Mice Arterioscler. Thromb. Vasc. Biol., October 1, 1995; 15(10): 1556 - 1562. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |